接受全髋关节置换术患者的髋关节色素沉着绒毛结节性滑膜炎:一项回顾性病例对照分析
该回顾性病例对照分析利用2005至2014年全国理赔登记数据,将1240例因髋关节色素沉着绒毛结节性滑膜炎(PVNS)行初次全髋关节置换术(THA)的患者与6200例对照按1:5匹配。结果显示PVNS患者住院时间延长约8%、医疗和植入物相关并发症风险及90天再入院风险升高,手术当日和90天费用也更高。
要点
- PVNS患者住院时间约延长8%(3.8天 vs 3.5天,P=.0006)。
- PVNS患者医疗并发症(OR 1.60)和植入物相关并发症(OR 1.81)风险升高。
- PVNS患者90天再入院风险升高(OR 1.84),手术当日及90天费用更高。
核心结论
- 在未控制2005至2014年间住院时间、并发症、再入院或费用总体趋势的情况下,研究结果提示髋关节PVNS与初次THA后更差结局和更高费用相关。
- 作者认为骨科医生可利用该研究向患者宣教髋部手术后可能发生的并发症。
研究设计与样本
- 回顾性病例对照分析,使用全国理赔登记数据识别2005至2014年因髋关节PVNS行初次THA的患者。
- PVNS患者按年龄、性别和多种合并症以1:5比例匹配对照,共纳入7440例,其中PVNS组1240例、对照组6200例。
- 采用多变量逻辑回归计算并发症的OR,Welch t检验比较住院时间和费用,P值小于.001视为有统计学意义。
主要发现
- PVNS患者住院时间约延长8%(3.8天 vs 3.5天,P=.0006)。
- PVNS患者医疗并发症风险升高(OR 1.60,P<.0001),植入物相关并发症风险升高(OR 1.81,P<.0001)。
- PVNS患者90天再入院风险升高(OR 1.84,P<.0001)。
- PVNS患者手术当日费用更高(13119美元 vs 11983美元,P<.0001),90天费用更高(17169美元 vs 15097美元,P<.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pigmented villonodular synovitis (PVNS) is a condition affecting larger joints such as the hip and knee. Little is known regarding the impact of PVNS on total hip arthroplasty (THA). Therefore, the aim of this study is to determine if patients with PVNS of the hip undergoing primary THA experience greater (1) in-hospital lengths of stay (LOS); (2) complications; (3) readmission rates; and (4) costs. METHODS: Patients undergoing primary THA for PVNS of the hip from the years 2005 to 2014 were identified using a nationwide claims registry. PVNS patients were matched to a control cohort in a 1:5 ratio by age, gender, and various comorbidities. The query yielded 7440 patients with (n = 1240) and without (n = 6200) PVNS of the hip undergoing primary THA. Endpoints analyzed included LOS, complications, readmission rates, and costs. Multivariate logistic regression was used to determine odds ratios (OR) of developing complications. Welch's t-tests were used to test for significance in LOS and cost between the cohorts. A P-value less than .001 was considered statistically significant. RESULTS: PVNS patients had approximately 8% longer in-hospital LOS (3.8 vs 3.5 days, P = .0006). PVNS patients had greater odds of (OR 1.60, P < .0001) medical and (OR 1.81, P < .0001) implant-related complications. Furthermore, PVNS patients were found to have higher odds (OR 1.84, P < .0001) of 90-day readmissions. PVNS patients also incurred higher day of surgery ($13,119 vs $11,983, P < .0001) and 90-day costs ($17,169 vs $15,097, P < .0001). CONCLUSION: Without controlling for global trends in LOS, complications, readmissions, or costs between 2005 and 2014, the findings of the study suggest that PVNS of the hip is associated with worse outcomes and higher costs following primary THA. The study is useful as orthopedic surgeons can use the study to educate patients of the complications which may occur following their hip surgery.
引用
- Ardeljan AD, Polisetty TS, Palmer JR, et al. Pigmented Villonodular Synovitis of the Hip in Patients Undergoing Total Hip Arthroplasty: A Retrospective Case-Controlled Analysis. J Arthroplasty. 2020. PMID: 32978024. doi:10.1016/j.arth.2020.08.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。